by The global catheter market, valued at USD 37.58 billion in 2024, is expected to reach USD 74.07 billion by 2034, growing at a CAGR of 7.09%.
Catheter Market Key Takeaways
- North America dominated the global catheter market in 2024, holding the highest share of 32%.
- The cardiovascular catheter segment led the market by product category in 2024.
- Among distribution channels, hospital stores accounted for the largest market share in 2024.
The global catheter market is experiencing steady growth, driven by rising demand for minimally invasive procedures and advancements in medical technology. In 2024, the market was valued at USD 37.58 billion and is projected to reach USD 74.07 billion by 2034, growing at a CAGR of 7.09%. North America led the market with a 32% share, reflecting strong healthcare infrastructure and increased adoption of advanced catheters. The cardiovascular catheter segment held the largest share among product categories, while hospital stores emerged as the dominant distribution channel. The market’s expansion is fueled by the growing prevalence of chronic diseases, increasing surgical procedures, and technological innovations in catheter design.
Sample Link: https://www.precedenceresearch.com/sample/1106
Key Drivers
Opportunities
- Growing demand for minimally invasive procedures is driving catheter adoption.
- Advancements in catheter technology, such as smart catheters and antimicrobial coatings, offer significant growth potential.
- Expanding healthcare infrastructure in emerging markets presents new opportunities for market penetration.
- Increasing awareness and diagnosis of chronic diseases boost the need for catheterization.
- Rising investments in R&D and favorable government policies support market expansion.
Challenges
- Risk of catheter-associated infections and complications can hinder market growth.
- High costs of advanced catheter technologies may limit adoption, especially in developing regions.
- Stringent regulatory approvals and compliance requirements pose challenges for new product launches.
- The presence of alternative treatment options may impact market demand.
- Supply chain disruptions and material shortages can affect production and distribution.
Regional Insights
North America dominates the global catheter market, holding the highest share due to advanced healthcare infrastructure, high adoption of innovative medical technologies, and the rising prevalence of chronic diseases. The United States is a key contributor, driven by strong research and development initiatives and increasing demand for minimally invasive procedures. Europe follows as a significant market, supported by well-established healthcare systems, government initiatives, and a growing aging population requiring catheterization.
The Asia-Pacific region is expected to witness the fastest growth, fueled by rising healthcare expenditures, improving medical facilities, and a large patient pool suffering from cardiovascular and urological disorders. Countries like China, India, and Japan are major growth contributors due to increasing awareness and healthcare advancements. Latin America and the Middle East & Africa are also experiencing steady growth, primarily due to expanding healthcare infrastructure and government efforts to improve medical access, although challenges like affordability and regulatory barriers remain.
Don’t Miss Out: Cosmetic Dentistry Market
Market Key Players
- Hollister Incorporated
- Teleflex Incorporation
- Bard
- Medtronic plc
- ConvaTec Group plc
- Cook Group
- Abbott Laboratories
- Boston Scientific Corporation
Recent News
In December 2024, Terumo Interventional Systems expanded its Radial-to-Peripheral (R2P) portfolio by launching the R2P™ NaviCross® peripheral support catheter in the U.S., aiming to enhance treatment options for peripheral artery disease. In February 2024, CERENOVUS, a division of Johnson & Johnson MedTech, introduced the CEREGLIDE™ 71 Intermediate Catheter, designed for revascularization in acute ischemic stroke patients. In March 2023, Shockwave Medical, Inc. announced the full U.S. commercial release of the Shockwave L6 Peripheral IVL Catheter, following FDA clearance, to address calcified lesions in large peripheral vessels.
In February 2022, Medtronic plc received FDA approval for its Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters, specifically developed to treat pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT). In February 2025, Johnson & Johnson paused U.S. sales of its Varipulse heart-rhythm device due to safety concerns, including reports of strokes in patients, impacting its strategic expansion into the heart-rhythm treatment market.
Market Segmentation
By Product
- Urology
- Peritoneal
- Intermittent
- External
- Hemodialysis
- Cardiovascular
- PTA Balloon
- Electrophysiology
- PTCA Balloon
- Intravascular Ultrasound
- Intravenous
- Peripheral
- Central Venous
- Midline Peripheral
- Specialty
- Oximetry
- Wound/ Surgical
- Intrauterine Insemination (IUI)
- Thermodilution
- Neurovascular
By Distribution Channel
- Retail Stores
- Hospital Stores
- Online Stores
By End User
- Hospitals
- Long-term Care Facilities
- Diagnostic Imaging Centers
- Other
By Lumen
- Single-lumen
- Double-lumen
- Triple-lumen
- Others
By Type
- Uncoated Catheters
- Coated Catheters
By Application
- Prostatic Hyperplasia General Surgeries
- Urinary Incontinence
- Others
